Biotricity Correlations

The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
  
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SRDXMODD
SRDXBSGM
BSGMMODD
MODDBBLG
NSYSMODD
NSYSHSCS
  
High negative correlations   
BMRABSGM
BMRAMODD
BMRASRDX
BSGMDCTH
BMRANSYS
BMRABBLG

Risk-Adjusted Indicators

There is a big difference between Biotricity OTC Stock performing well and Biotricity OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biotricity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CVRX  3.11  0.00  0.00 (0.10) 0.00 
 5.58 
 14.59 
BBLG  3.56 (0.34) 0.00 (0.36) 0.00 
 9.80 
 23.26 
DCTH  2.83  0.45  0.11  0.15  3.22 
 5.56 
 20.56 
HSCS  3.06 (0.29) 0.00 (1.93) 0.00 
 6.41 
 19.85 
MODD  2.81 (0.85) 0.00 (1.66) 0.00 
 4.76 
 18.21 
NSYS  1.91 (0.25) 0.00 (0.54) 0.00 
 4.49 
 9.97 
PETV  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BSGM  6.99 (0.54) 0.00  0.14  0.00 
 14.62 
 45.61 
SRDX  1.47 (0.40) 0.00 (0.82) 0.00 
 1.74 
 10.84 
BMRA  8.64  2.21  0.32  1.32  5.87 
 17.86 
 113.97 

View Biotricity Related Equities

 Risk & Return  Correlation

Biotricity Corporate Management

Elected by the shareholders, the Biotricity's board of directors comprises two types of representatives: Biotricity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotricity. The board's role is to monitor Biotricity's management team and ensure that shareholders' interests are well served. Biotricity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotricity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fareeha SiddiquiSenior SolutionsProfile
Amjad TalpurSenior OperationsProfile
Amir AliChief OfficerProfile
John AyanoglouChief OfficerProfile
Andy WongVice OperationsProfile

Still Interested in Biotricity?

Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.